Literature DB >> 23920789

A study of user requests regarding the fully electronic health record system at Seoul National University Bundang Hospital.

Sooyoung Yoo1, Seok Kim, Kee-Hyuck Lee, Rong-Min Baek, Hee Hwang.   

Abstract

Although the adoption rates for Electronic Health Records (EHRs) are growing, significant opportunities for further advances in EHR system design remain. The goal of this study was to identify issues that should be considered in the design process for the successful development of future systems by analyzing end users' service requests gathered during a recent three-year period after a comprehensive EHR system was implemented at Seoul National University's Bundang Hospital (SNUBH) in South Korea. Data on service requests from end users of the EHR system made from 2008 through 2010 were analyzed and categorized. From our study, we found that the EHR system has evolved to optimize ease of use and special functionalities for particular groups of users and particular subspecialties.

Mesh:

Year:  2013        PMID: 23920789

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  3 in total

1.  Predictors of Increased Risk of Hepatocellular Carcinoma in Patients with Type 2 Diabetes.

Authors:  Won Keun Si; Jung Wha Chung; Junhyeon Cho; Joo Yeong Baeg; Eun Sun Jang; Hyuk Yoon; Jaihwan Kim; Cheol Min Shin; Young Soo Park; Jin-Hyeok Hwang; Sook-Hyang Jeong; Nayoung Kim; Dong Ho Lee; Soo Lim; Jin-Wook Kim
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

2.  Development of a nomogram for screening of hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Jung Wha Chung; Eun Sun Jang; Jaihwan Kim; Sook-Hyang Jeong; Nayoung Kim; Dong Ho Lee; Kyung Ho Lee; Jin-Wook Kim
Journal:  Oncotarget       Date:  2017-11-18

3.  A scoring system for predicting hepatocellular carcinoma risk in alcoholic cirrhosis.

Authors:  Kyunghan Lee; Gwang Hyeon Choi; Eun Sun Jang; Sook-Hyang Jeong; Jin-Wook Kim
Journal:  Sci Rep       Date:  2022-02-02       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.